2021 INS STANDARDS
New Standard Recognizes Anti-Reflux
“Anti-reflux devices containing a bidirectional, pressure-sensitive valve have the least amount of reflux”
TKO PERFORMANCE
New Anti-Reflux Evidence
Nexus TKO-6P produces the least amount of reflux compared to positive, negative, or neutral needleless connectors.
Have you downloaded the 2020 Journal of Vascular Access Study?
TKO DIFFERENCE
5-Years of Reduced CVAD Occlusions with TKO
Study shows a 69% CVAD occlusion reduction was sustained using TKO in place of a negative needleless connector.
Have you downloaded the 2020 Journal of Vascular Access Study?
TKO Resources
89% success rate with 1 IV per patient visit
Study shows occlusion improvements with TKO compared to neutral needleless connector.
Right Approach for the Right Result—find out how to deliver 1 IV per patient visit
Nexus TKO for Home Infusion
Treat Patients, Not Problems
The Nexus TKO 6P-HV is proven to reduce alteplase use by preventing occlusions in the first place,
so you can spend more time healing your patients instead of treating problems.
Nexus TKO technology offers 24/7 protection against intraluminal occlusions.
TKO PERFORMANCE
New Anti-Reflux Evidence
Nexus TKO-6P produces the least amount of reflux compared to
positive, negative, or neutral needleless connectors.
2021 INS STANDARDS
New Standard Recognizes Anti-Reflux
“Anti-reflux devices containing a bidirectional, pressure-sensitive valve
have the least amount of reflux”
TKO DIFFERENCE
5-Years of Reduced CVAD Occlusions with TKO
Study shows a 69% CVAD occlusion reduction was sustained
using TKO in place of a negative needleless connector.